Eric Aguiar
CIK: 0001262325
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 22, 2026BBIO
BridgeBio Pharma, Inc.
Award(A)Direct4K shares- - Jun 10, 2026BMEA
Biomea Fusion, Inc.
Award(A)DirectStock Option (Right to Buy)
196.3K shares- - Jun 20, 2025BBIO
BridgeBio Pharma, Inc.
Award(A)Direct6.6K shares- - Jun 11, 2025BMEA
Biomea Fusion, Inc.
Award(A)DirectStock Option (Right to Buy)
92K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 22, 2026 |  BBIO BridgeBio Pharma, Inc. | Award(A) | 3,990 | - | $0 | Direct |
| Jun 10, 2026 |  BMEA Biomea Fusion, Inc. | Award(A) Stock Option (Right to Buy) | 196,299 | - | - | Direct |
| Jun 20, 2025 | BBIO BridgeBio Pharma, Inc. | Award(A) | 6,589 | - | - | Direct |
| Jun 11, 2025 | BMEA Biomea Fusion, Inc. | Award(A) Stock Option (Right to Buy) | 91,970 | - | - | Direct |
1-4 of 4 transactions
About AGUIAR ERIC
AGUIAR ERIC (SEC CIK 0001262325) files insider reports with the SEC as Director of BridgeBio Pharma, Inc. (BBIO) and Director of Biomea Fusion, Inc. (BMEA).
Signal8 holds 4 ownership filings by AGUIAR ERIC, all Form 4s, filed between Jun 13, 2025 and Jun 24, 2026. Those filings report 4 transactions, from Jun 11, 2025 to Jun 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on AGUIAR ERIC's filings is in SAN CARLOS, CA.
Recent filings by AGUIAR ERIC
Other insiders filing for BridgeBio Pharma, Inc. (BBIO)
- Kumar Neil, Chief Executive Officer
- Trimarchi Thomas, President and CFO
- Apuli Maricel, Chief Accounting Officer
- Ellis Andrea, Director
- Cook Jennifer E., Director
- Valantine Hannah, Director